BML Capital Management as of Sept. 30, 2023
Portfolio Holdings for BML Capital Management
BML Capital Management holds 26 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ishares Tr 0-3 Mnth Treasry (SGOV) | 25.0 | $27M | 270k | 100.67 | |
| Spdr Ser Tr Bloomberg 1-3 Mo (BIL) | 16.9 | $18M | 200k | 91.82 | |
| Atea Pharmaceuticals (AVIR) | 13.2 | $14M | 4.8M | 3.00 | |
| Cyteir Therapeutics | 8.5 | $9.2M | 3.3M | 2.84 | |
| Avrobio Ord (AVRO) | 5.7 | $6.2M | 4.0M | 1.54 | |
| Adverum Biotechnologies | 5.4 | $5.9M | 3.9M | 1.50 | |
| Talaris Therapeutics | 5.2 | $5.6M | 2.0M | 2.81 | |
| Eliem Therapeutics (ELYM) | 4.7 | $5.1M | 1.9M | 2.63 | |
| Athira Pharma (ATHA) | 3.2 | $3.4M | 1.7M | 2.02 | |
| Astrotech Corp (ASTC) | 2.0 | $2.2M | 220k | 10.10 | |
| Oramed Pharmaceuticals Com New (ORMP) | 1.9 | $2.0M | 781k | 2.61 | |
| Arca Biopharma (ABIO) | 1.3 | $1.4M | 707k | 2.01 | |
| Passage Bio (PASG) | 1.2 | $1.4M | 2.1M | 0.66 | |
| Forte Biosciences (FBRX) | 1.1 | $1.2M | 1.8M | 0.66 | |
| Milestone Pharmaceuticals (MIST) | 0.8 | $845k | 273k | 3.10 | |
| Enliven Therapeutics (ELVN) | 0.6 | $683k | 50k | 13.66 | |
| Retractable Technologies (RVP) | 0.5 | $595k | 500k | 1.19 | |
| Verrica Pharmaceuticals (VRCA) | 0.5 | $583k | 150k | 3.88 | |
| Vistagen Therapeutics Ord (VTGN) | 0.5 | $524k | 100k | 5.24 | |
| Lisata Therapeutics (LSTA) | 0.5 | $522k | 244k | 2.14 | |
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 0.4 | $444k | 108.00 | 4110.00 | |
| Nextcure (NXTC) | 0.4 | $395k | 307k | 1.29 | |
| Neoleukin Therapeutics Com New | 0.4 | $390k | 99k | 3.95 | |
| Calcimedica Com New (CALC) | 0.2 | $236k | 89k | 2.66 | |
| Rain Therapeutics | 0.1 | $63k | 73k | 0.86 | |
| Surrozen | 0.0 | $44k | 89k | 0.49 |
